Current thinking on the mechanistic basis of Alzheimer's and implications for drug development-Reference-Cited by-同舟云学术

Current thinking on the mechanistic basis of Alzheimer's and implications for drug development

Published:2015-09-10 Issue:5 Volume:98 Page:469-471
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Ising C¹,Stanley M¹,Holtzman DM¹

Affiliation:

1. Department of Neurology; Hope Center for Neurological Disorders, Charles F and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine; St. Louis Missouri USA

Funder

The JPB Foundation and Cure Alzheimer's Fund

National Science Foundation graduate research fellowship

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.200/fullpdf

Reference5 articles.

1. Three dimensions of the amyloid hypothesis: time, space and “wingmen”;Musiek;Nat. Neurosci.,2015

2. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology;Serrano-Pozo;Brain,2010

3. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis;Kayed;Science,2003

4. Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis;Kim;J. Exp. Med.,2012

5. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model;Wang;Cell,2015

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early onset diagnosis in Alzheimer’s disease patients via amyloid-β oligomers-sensing probe in cerebrospinal fluid;Nature Communications;2024-02-02

2. Pioneering the Early Diagnosis of Alzheimer’s Disease: Aβ Oligomers-Sensing Probe for Cerebrospinal Fluid Analysis in Patients;2023-03-27

3. Cognitive interventions for memory and psychological well-being in aging and dementias;Frontiers in Psychology;2023-02-02

4. Effects of Aducanumab on treating Alzheimer’s disease: targets and clinical trials;Highlights in Science, Engineering and Technology;2022-07-27

5. Lights and Shadows of Cerebrospinal Fluid Biomarkers in the Current Alzheimer’s Disease Framework;Journal of Alzheimer's Disease;2022-04-05